Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung Adenocarcinoma

Immune checkpoint inhibitors have changed the landscape of classic cancer treatment. However, their use is associated with the emergence of new adverse events. An elderly man with rheumatoid arthritis was started on pembrolizumab for newly diagnosed advanced lung cancer. He subsequently developed he...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Intern Med
Autors principals: Akagi, Yu, Awano, Nobuyasu, Inomata, Minoru, Kuse, Naoyuki, Tone, Mari, Yoshimura, Hanako, Jo, Tatsunori, Takada, Kohei, Kumasaka, Toshio, Izumo, Takehiro
Format: Artigo
Idioma:Inglês
Publicat: The Japanese Society of Internal Medicine 2020
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7205536/
https://ncbi.nlm.nih.gov/pubmed/32009093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.3889-19
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars